ask="4.90"
ask_size="2000"
average_daily_volume="12650"
bid="N/A"
bid_size="N/A"
book_value="-2.05"
change="+0.03"
change_from_200_day_moving_average="-0.23"
change_from_50_day_moving_average="-0.08"
change_from_52_week_high="-1.43"
change_From_52_week_low="0.24"
change_in_percent="+0.72%"
close="4.17"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.88"
ebitda="-3.99M"
eps_estimate_current_year="-2.95"
eps_estimate_next_quarter="-0.13"
eps_estimate_next_year="-0.48"
ex_dividend_date="N/A"
float_shares="2882000"
high="4.30"
high_52_weeks="5.60"
last_trade_date="3/7/2017"
last_trade_price="4.17"
last_trade_size="963"
last_trade_time="3:58pm"
low="4.05"
low_52_weeks="3.93"
market_capitalization="40.16M"
moving_average_200_day="4.40"
moving_average_50_day="4.25"
name="AzurRx BioPharma
Inc."
notes="N/A"
one_year_target_price="7.00"
open="4.14"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-5.17%"
percent_change_from_50_day_moving_average="-1.89%"
percent_change_from_52_week_high="-25.54%"
percent_change_from_52_week_low="+6.11%"
previous_close="4.14"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="9631000"
short_ratio="2.31"
stock_exchange="NCM"
symbol="AZRX"
volume="32711"
weeks_range_52="3.93 - 5.60"
